NINDS epilepsy and autism spectrum disorders workshop report

Neurology

Volumn 81, Issue 18, 2013, Pages 1630-1636

  Tuchman, Roberto ^a   Hirtz, Deborah ^b   Mamounas, Laura A ^b  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARBACLOFEN; FENOBAM; GABOXADOL; GANAXOLONE;

ARTICLE; AUTISM; BASIC RESEARCH; CLINICAL RESEARCH; CONTROLLED CLINICAL TRIAL (TOPIC); ENVIRONMENTAL FACTOR; EPILEPSY; FRAGILE X SYNDROME; HUMAN; NATIONAL HEALTH ORGANIZATION; NERVE CELL PLASTICITY; NEUROIMAGING; NEUROPATHOLOGY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; RETT SYNDROME; TUBEROUS SCLEROSIS; WORKSHOP; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ENVIRONMENT; GENETICS; MEDICAL RESEARCH; UNITED STATES;

BIOMEDICAL RESEARCH; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ENVIRONMENT; EPILEPSY; HUMANS; NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (U.S.); NEUROIMAGING; UNITED STATES;

EID: 84888224094     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a9f482     Document Type: Article

References (60)

1. Berg AT, Jallon P, Preux PM. The epidemiology of seizure disorders in infancy and childhood: definitions and classifications. Handb Clin Neurol 2013;111:391-398.
2. Suren P, Bakken IJ, Aase H, et al. Autism spectrum disorder, ADHD, epilepsy, and cerebral palsy in Norwegian children. Pediatrics 2012;130:e152-e158.
3. Schieve LA, Rice C, Yeargin-AllsoppM, et al. Parent-reported prevalence of autism spectrum disorders in US-born children: an assessment of changes within birth cohorts from the 2003 to the 2007 National Survey of Children's Health. Matern Child Health J 2012;16(suppl 1):S151-S157.
4. Charman T, Pickles A, Simonoff E, Chandler S, Loucas T, Baird G. IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP). Psychol Med 2011;41:619-627.
5. Berg AT, Plioplys S. Epilepsy and autism: Is there a special relationship? Epilepsy Behav 2012;23:193-198.
6. Amiet C, Gourfinkel-An I, Bouzamondo A, et al. Epilepsy in autism is associated with intellectual disability and gender: evidence from a meta-analysis. Biol Psychiatry 2008;64:577-582.
7. Woolfenden S, Sarkozy V, Ridley G, CooryM, Williams K. A systematic review of two outcomes in autism spectrum disorder: epilepsy and mortality. Dev Med Child Neurol 2012;54: 306-312.
8. Bolton PF, Carcani-Rathwell I, Hutton J, Goode S, Howlin P, Rutter M. Epilepsy in autism: features and correlates. Br J Psychiatry 2011;198:289-294.
9. Geerts A, Brouwer O, van Donselaar C, et al. Health perception and socioeconomic status following childhood- onset epilepsy: the Dutch study of epilepsy in childhood. Epilepsia 2011;52:2192-2202.
10. Berg AT, Plioplys S, Tuchman R. Risk and correlates of autism spectrum disorder in children with epilepsy: a community- based study. J Child Neurol 2011;26:540-547.
11. Rai D, Kerr MP, McManus S, Jordanova V, Lewis G, Brugha TS. Epilepsy and psychiatric comorbidity: a nationally representative population-based study. Epilepsia 2012;53:1095-1103.
12. Brooks-Kayal A. Molecular mechanisms of cognitive and behavioral comorbidities of epilepsy in children. Epilepsia 2011;52(suppl 1):13-20.
13. Mefford HC, Muhle H, Ostertag P, et al. Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies. PLoS Genet 2010;6:e1000962.
14. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res 2011;1380:42-77.
15. Mulley JC, Mefford HC. Epilepsy and the new cytogenetics. Epilepsia 2011;52:423-432.
16. Mefford HC, Batshaw ML, Hoffman EP. Genomics, intellectual disability, and autism. N Engl J Med 2012; 366:733-743.
17. Jensen FE. Epilepsy as a spectrum disorder: implications from novel clinical and basic neuroscience. Epilepsia 2011; 52(suppl 1):1-6.
18. Galanopoulou AS, Moshe SL. The epileptic hypothesis: developmentally related arguments based on animal models. Epilepsia 2009;50(suppl 7):37-42.
19. Rakhade SN, Jensen FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009;5: 380-391.
20. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005;57:67-81.
21. Choi J, Nordli DR Jr, Alden TD, et al. Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009;6:38.
22. van Eeghen AM, Pulsifer MB, Merker VL, et al. Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol 2013;55:146-153.
23. Sahin M. Targeted treatment trials for tuberous sclerosis and autism: no longer a dream. Curr Opin Neurobiol 2012;22:895-901.
24. Khwaja OS, Sahin M. Translational research: Rett syndrome and tuberous sclerosis complex. Curr Opin Pediatr 2011;23:633-639.
25. Numis AL, Major P, Montenegro MA, Muzykewicz DA, Pulsifer MB, Thiele EA. Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex. Neurology 2011;76:981-987.
26. Tsai P, Sahin M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol 2011;24:106-113.
27. Fu C, Cawthon B, Clinkscales W, Bruce A, Winzenburger P, Ess KC. GABAergic interneuron development and function is modulated by the Tsc1 gene. Cereb Cortex 2012;22:2111-2119.
28. Talos DM, Sun H, Zhou X, et al. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLoS One 2012;7:e35885.
29. Hagerman PJ, Stafstrom CE. Origins of epilepsy in fragile X syndrome. Epilepsy Curr 2009;9:108-112.
30. Harris SW, Hessl D, Goodlin-Jones B, et al. Autism profiles of males with fragile X syndrome. Am J Ment Retard 2008;113:427-438.
31. Darnell JC, Van Driesche SJ, Zhang C, et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2011;146:247-261.
32. Paluszkiewicz SM, Martin BS, Huntsman MM. Fragile X syndrome: the GABAergic system and circuit dysfunction. Dev Neurosci 2011;33:349-364.
33. Chonchaiya W, Au J, Schneider A, et al. Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder. Hum Genet 2012;131:581-589.
34. Stafstrom CE, Hagerman PJ, Pessah IN. Pathophysiology of epilepsy in autism spectrum disorders. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds. Jasper's Basic Mechanisms of the Epilepsies. 4th ed. Bethesda: National Center for Biotechnology Information; 2012.
35. Hagerman R, Lauterborn J, Au J, Berry-Kravis E. Fragile X syndrome and targeted treatment trials. Results Probl Cell Differ 2012;54:297-335.
36. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999;23:185-188.
37. Gatto CL, Broadie K. Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Synaptic Neurosci 2010;2:4.
38. Cukier HN, Lee JM, Ma D, et al. The expanding role of MBD genes in autism: identification of a MECP2 duplication and novel alterations in MBD5, MBD6, and SETDB1. Autism Res 2012;5:385-397.
39. Guerrini R, Parrini E. Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies. Epilepsia 2012;53:2067-2078.
40. Nissenkorn A, Gak E, Vecsler M, Reznik H, Menascu S, Ben Zeev B. Epilepsy in Rett syndrome: the experience of a National Rett Center. Epilepsia 2010;51:1252-1258.
41. Calfa G, Percy AK, Pozzo-Miller L. Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med 2011;236:3-19.
42. Chao HT, Chen H, Samaco RC, et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010;468:263-269.
43. McLeod F, Ganley R, Williams L, Selfridge J, Bird A, Cobb SR. Reduced seizure threshold and altered network oscillatory properties in a mouse model of Rett syndrome. Neuroscience 2013;231:195-205.
44. Tanaka M, DeLorey TM, Delgado-Escueta A, Olsen RW. GABRB3, epilepsy, and neurodevelopment. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, eds. Jasper's Basic Mechanisms of the Epilepsies. 4th ed. Bethesda: National Center for Biotechnology Information; 2012.
45. Tuchman R, Moshe SL, Rapin I. Convulsing toward the pathophysiology of autism. Brain Dev 2009;31:95-103.
46. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. Minicolumnar pathology in autism. Neurology 2002;58: 428-432.
47. Anagnostou E, Taylor MJ. Review of neuroimaging in autism spectrum disorders: what have we learned and where we go from here? Mol Autism 2011;2:4.
48. Wegiel J, Kuchna I, Nowicki K, et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol 2010;119:755- 770.
49. Holmes GL. Effects of early seizures on later behavior and epileptogenicity. Ment Retard Dev Disabil Res Rev 2004; 10:101-105.
50. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010;51:676-685.
51. Galanopoulou AS, Moshe SL. In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies. Biomark Med 2011;5:615-628.
52. Giorgi FS, Veliskova J, Chudomel O, Kyrozis A, Moshe SL. The role of substantia nigra pars reticulata in modulating clonic seizures is determined by testosterone levels during the immediate postnatal period. Neurobiol Dis 2007;25:73-79.
53. Kyrozis A, Chudomel O, Moshe SL, Galanopoulou AS. Sex-dependent maturation of GABAA receptor-mediated synaptic events in rat substantia nigra reticulata. Neurosci Lett 2006;398:1-5.
54. Lesca G, Rudolf G, Labalme A, et al. Epileptic encephalopathies of the Landau-Kleffner and continuous spike and waves during slow-wave sleep types: genomic dissection makes the link with autism. Epilepsia 2012;53:1526- 1538.
55. Malow BA. The interaction between sleep and epilepsy. Epilepsia 2007;48(suppl 9):36-38.
56. Dawson G, Rogers S, Munson J, et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model. Pediatrics 2010;125:e17-e23.
57. Dawson G, Jones EJ, Merkle K, et al. Early behavioral intervention is associated with normalized brain activity in young children with autism. J Am Acad Child Adolesc Psychiatry 2012;51:1150-1159.
58. Ku CS, Polychronakos C, Tan EK, et al. A new paradigm emerges from the study of de novo mutations in the context of neurodevelopmental disease. Mol Psychiatry 2013; 18:141-153.
59. Pestian J, Spencer M, Matykiewicz P, Zhang K, Vinks AA, Glauser T. Personalizing drug Selection using advanced clinical decision support. Biomed Inform Insights 2009; 2:19-29.
60. Jeste SS. The neurology of autism spectrum disorders. Curr Opin Neurol 2011;24:132-139.